Stati Uniti - inglese - NLM (National Library of Medicine)

eisai inc. - alitretinoin (unii: 1ua8e65kdz) (alitretinoin - unii:1ua8e65kdz) - alitretinoin 60 mg in 60 g - panretin® gel is indicated for topical treatment of cutaneous lesions in patients with aids-related kaposi’s sarcoma. panretin® gel is not indicated when systemic anti-ks therapy is required (e.g., more than 10 new ks lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary ks, or symptomatic visceral involvement). there is no experience to date using panretin® gel with systemic anti-ks treatment. panretin® gel is contraindicated in patients with a known hypersensitivity to retinoids or to any of the ingredients of the product.

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

drug tariff special order - acitretin - oral suspension - 1mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - acitretin - oral solution - 1mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - acitretin - oral suspension - 2mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - acitretin - oral solution - 2mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - acitretin - oral capsule - 10mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - acitretin - oral capsule - 25mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - alitretinoin - oral capsule - 10mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - alitretinoin - oral capsule - 30mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - alitretinoin - oral capsule - 10mg